PTC Therapeutics, Inc. Gain (Loss) on Termination of Lease
PTC Therapeutics, Inc. (PTCT) reported Gain (Loss) on Termination of Lease of $2.18 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-02-19
- PTC Therapeutics, Inc. gain (loss) on termination of lease for the quarter ending 2024-06-30 was $2.20M.
- PTC Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2024 was $2.18M.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.18M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $2.18M 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | $2.20M 10-Q · filed 2025-08-07 | $2.18M 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |